570 related articles for article (PubMed ID: 25088843)
1. THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial.
Koga M; Toyoda K; Kimura K; Yamamoto H; Sasaki M; Hamasaki T; Kitazono T; Aoki J; Seki K; Homma K; Sato S; Minematsu K;
Int J Stroke; 2014 Dec; 9(8):1117-24. PubMed ID: 25088843
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy.
Toyoda K; Inoue M; Yoshimura S; Yamagami H; Sasaki M; Fukuda-Doi M; Kimura K; Asakura K; Miwa K; Kanzawa T; Ihara M; Kondo R; Shiozawa M; Ohtaki M; Kamiyama K; Itabashi R; Iwama T; Aoki J; Minematsu K; Yamamoto H; Koga M;
Stroke; 2021 Jan; 52(1):12-19. PubMed ID: 33297866
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.
Koga M; Yamamoto H; Inoue M; Asakura K; Aoki J; Hamasaki T; Kanzawa T; Kondo R; Ohtaki M; Itabashi R; Kamiyama K; Iwama T; Nakase T; Yakushiji Y; Igarashi S; Nagakane Y; Takizawa S; Okada Y; Doijiri R; Tsujino A; Ito Y; Ohnishi H; Inoue T; Takagi Y; Hasegawa Y; Shiokawa Y; Sakai N; Osaki M; Uesaka Y; Yoshimura S; Urabe T; Ueda T; Ihara M; Kitazono T; Sasaki M; Oita A; Yoshimura S; Fukuda-Doi M; Miwa K; Kimura K; Minematsu K; Toyoda K;
Stroke; 2020 May; 51(5):1530-1538. PubMed ID: 32248771
[TBL] [Abstract][Full Text] [Related]
5. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C;
N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial.
Schlemm L; Braemswig TB; Boutitie F; Vynckier J; Jensen M; Galinovic I; Simonsen CZ; Cheng B; Cho TH; Fiehler J; Puig J; Thijs V; Fiebach J; Muir K; Nighoghossian N; Ebinger M; Pedraza S; Thomalla G; Gerloff C; Endres M; Lemmens R; Nolte CH;
Neurology; 2022 Jan; 98(3):e302-e314. PubMed ID: 34782419
[TBL] [Abstract][Full Text] [Related]
7. Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.
Ringleb P; Bendszus M; Bluhmki E; Donnan G; Eschenfelder C; Fatar M; Kessler C; Molina C; Leys D; Muddegowda G; Poli S; Schellinger P; Schwab S; Serena J; Toni D; Wahlgren N; Hacke W;
Int J Stroke; 2019 Jul; 14(5):483-490. PubMed ID: 30947642
[TBL] [Abstract][Full Text] [Related]
8. Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results.
Schwamm LH; Wu O; Song SS; Latour LL; Ford AL; Hsia AW; Muzikansky A; Betensky RA; Yoo AJ; Lev MH; Boulouis G; Lauer A; Cougo P; Copen WA; Harris GJ; Warach S;
Ann Neurol; 2018 May; 83(5):980-993. PubMed ID: 29689135
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP Trial.
Cheng B; Boutitie F; Nickel A; Wouters A; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Galinovic I; Puig J; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G;
Stroke; 2020 Jan; 51(1):209-215. PubMed ID: 31662118
[TBL] [Abstract][Full Text] [Related]
10. Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial).
Thomalla G; Boutitie F; Fiebach JB; Simonsen CZ; Nighoghossian N; Pedraza S; Lemmens R; Roy P; Muir KW; Ebinger M; Ford I; Cheng B; Galinovic I; Cho TH; Puig J; Thijs V; Endres M; Fiehler J; Gerloff C;
Stroke; 2017 Mar; 48(3):770-773. PubMed ID: 28174327
[TBL] [Abstract][Full Text] [Related]
11. Thrombolysis for Acute Wake-Up and Unclear-Onset Strokes with Alteplase at 0.6 mg/kg in Clinical Practice: THAWS2 Study.
Yoshimura S; Koga M; Okada T; Inoue M; Miwa K; Fukuda-Doi M; Kondo R; Inoue T; Ichijo M; Ohtaki M; Nagakane Y; Itabashi R; Sakai N; Kimura K; Kamiyama K; Shiokawa Y; Yagita Y; Iwama T; Yakushiji Y; Kusumi M; Yamaki T; Uemura J; Yasuura A; Noshiro S; Fukunaga D; Yazawa Y; Aoki J; Yoshikawa M; Ihara M; Toyoda K;
Cerebrovasc Dis; 2024; 53(1):46-53. PubMed ID: 37263235
[TBL] [Abstract][Full Text] [Related]
12. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
[TBL] [Abstract][Full Text] [Related]
13. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
Campbell BCV; Ma H; Ringleb PA; Parsons MW; Churilov L; Bendszus M; Levi CR; Hsu C; Kleinig TJ; Fatar M; Leys D; Molina C; Wijeratne T; Curtze S; Dewey HM; Barber PA; Butcher KS; De Silva DA; Bladin CF; Yassi N; Pfaff JAR; Sharma G; Bivard A; Desmond PM; Schwab S; Schellinger PD; Yan B; Mitchell PJ; Serena J; Toni D; Thijs V; Hacke W; Davis SM; Donnan GA;
Lancet; 2019 Jul; 394(10193):139-147. PubMed ID: 31128925
[TBL] [Abstract][Full Text] [Related]
14. [EU-funded treatment study: WAKE-UP: a randomized, placebo-controlled MRI-based trial of thrombolysis in wake-up stroke].
Thomalla G; Ebinger M; Fiehler J; Fiebach JB; Endres M; Gerloff C
Nervenarzt; 2012 Oct; 83(10):1241-51. PubMed ID: 23015193
[TBL] [Abstract][Full Text] [Related]
15. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
[TBL] [Abstract][Full Text] [Related]
16. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.
Thomalla G; Boutitie F; Ma H; Koga M; Ringleb P; Schwamm LH; Wu O; Bendszus M; Bladin CF; Campbell BCV; Cheng B; Churilov L; Ebinger M; Endres M; Fiebach JB; Fukuda-Doi M; Inoue M; Kleinig TJ; Latour LL; Lemmens R; Levi CR; Leys D; Miwa K; Molina CA; Muir KW; Nighoghossian N; Parsons MW; Pedraza S; Schellinger PD; Schwab S; Simonsen CZ; Song SS; Thijs V; Toni D; Hsu CY; Wahlgren N; Yamamoto H; Yassi N; Yoshimura S; Warach S; Hacke W; Toyoda K; Donnan GA; Davis SM; Gerloff C;
Lancet; 2020 Nov; 396(10262):1574-1584. PubMed ID: 33176180
[TBL] [Abstract][Full Text] [Related]
17. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
Lorenzano S; Toni D;
Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
[TBL] [Abstract][Full Text] [Related]
18. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging-Guided Intravenous Thrombolysis in Cardioembolic Stroke Patients With Unknown Time of Onset - Subanalysis of the THAWS Randomized Control Trial.
Yamazaki N; Koga M; Doijiri R; Inoue M; Miwa K; Yoshimura S; Fukuda-Doi M; Aoki J; Asakura K; Sasaki M; Kitazono T; Kimura K; Minematsu K; Yamamoto H; Ihara M; Toyoda K;
Circ J; 2024 Feb; 88(3):382-387. PubMed ID: 38220173
[TBL] [Abstract][Full Text] [Related]
20. Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial.
Barow E; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Ford I; Galinovic I; Nickel A; Puig J; Roy P; Wouters A; Magnus T; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G;
JAMA Neurol; 2019 Jun; 76(6):641-649. PubMed ID: 30907934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
